Frazier Life Sciences Public Fund, L.P. 13D and 13G filings for Xilio Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-13 5:31 pm Sale | 2025-12-31 | 13G | XILIO THERAPEUTICS INC XLO | Frazier Life Sciences Public Fund, L.P. | 334,034 6.700% | -247,467 (-42.56%) | Filing |
| 2025-08-14 1:47 pm Purchase | 2025-06-30 | 13G | XILIO THERAPEUTICS INC XLO | Frazier Life Sciences Public Fund, L.P. | 581,501 9.900% | 170,987 (+41.65%) | Filing |
| 2025-06-12 4:55 pm Purchase | 2025-06-05 | 13G | XILIO THERAPEUTICS INC XLO | Frazier Life Sciences Public Fund, L.P. | 410,514 9.900% | 410,514 (New Position) | Filing |